Quick Links

Joseph Rosenthal named interim pediatrics chair 

 


By Darrin S. Joy


Photo of Joseph RosenthalJoseph Rosenthal (Photo by Paula Myers)
City of Hope has named Joseph Rosenthal, M.D., as interim chair of the Department of Pediatrics. The physician and researcher replaces Judith Sato, M.D., who resigned as interim chair to focus on research and patient-care efforts.

Rosenthal, who continues as director of the Pediatric Hematopoietic Cell Transplantation Program and associate professor of pediatrics, will continue to advance the department’s objectives of providing excellent care to pediatric patients while conducting research to develop new treatments, said Alexandra Levine, M.D., chief medical officer.

“Dr. Rosenthal is a nationally respected clinician and researcher with extensive expertise in pediatric clinical trials, as well as transplant studies,” said Levine. “He’s very accomplished and will lead the department well.”

Rosenthal took the departmental helm on July 31. “It is an honor and a great responsibility to be leading such a talented faculty and staff in our ongoing common commitment to fight in the frontline of the battle against childhood cancer, other life-threatening hematological disorders and the long-term consequences of treatment,” he said.

Photo of Judith SatoJudith Sato (Photo by Walter Urie)
Rosenthal joined City of Hope in 1996 following a decade of experience in pediatric hematology and oncology research and treatment in Israel. He has led numerous studies investigating novel treatments for many hematologic malignancies.

He received his medical degree from Tel Aviv University, and he holds a master of science degree in health-care management from the Harvard School of Public Health.

Levine also expressed thanks to Sato for her leadership as interim chair and expressed enthusiasm for Sato’s shift of priorities. “Today, City of Hope has one of the most successful pediatric oncology programs in the state, and under Dr. Sato’s leadership, the department has contributed to numerous scientific and medical advances,” she said. “I look forward to her continued efforts as director of the Musculoskeletal Tumor Program.”

 Search

Go!
Advanced Search Options
News & Publications Search